Authors: Berentsen, S Tjonnfjord, GE Brudevold, R Gjertsen, BT Langholm, R Lokkevik, E Sorbo, JH Ulvestad, E

Citation: S. Berentsen et al., Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease, BR J HAEM, 115(1), 2001, pp. 79-83

Authors: Berentsen, S Tjonnfjord, GE Shammas, FV Bergheim, J Hammerstrom, J Langholm, R Ulvestad, E

Citation: S. Berentsen et al., No response to cladribine in five patients with chronic cold agglutinin disease, EUR J HAEMA, 65(1), 2000, pp. 88-90

Authors: Lote, K Holte, H Nome, O Langholm, R Kvaloy, S

Citation: K. Lote et al., Stage I high-grade non-Hodgkin's lymphoma, ACTA ONCOL, 39(7), 2000, pp. 865-872

Authors: Holte, H Suo, Z Smeland, EB Kvaloy, S Langholm, R Stokke, T

Citation: H. Holte et al., Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers, ACTA ONCOL, 38(4), 1999, pp. 495-503